Molecular Ontogeny Underlies the Benefit of Adding Venetoclax to Hypomethylating Agents in Newly Diagnosed AML PatientsShai Shimony,Jacqueline S. Garcia,Julia Keating,Evan C. Chen,Marlise R. Luskin,Maximilian Stahl,Donna S. Neuberg,Daniel J. DeAngelo,Richard M. Stone,R. Coleman LindsleyLEUKEMIA（2024）引用 3|浏览24关键词Hematologic Malignancies,AMLAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
